Skip to main content
SpringerLink
Log in
Book cover

The Biology and Prevention of Aerodigestive Tract Cancers pp 111–117Cite as

Participant Enrollment, Participation, and Compliance in Chemoprevention Trials

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 320))

Abstract

Until recently, efforts at cancer prevention were limited primarily to smoking cessation and the avoidance of occupational exposure to carcinogens. Today, these, efforts have expanded to include not only dietary modification for the prevention of breast and colon cancers but also treatments with a wide array of chemopreventive agents.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Meyskens FL Jr. The place of chemoprevention studies in cancer prevention planning. In Mettlin CJ, Aoki K (eds): Recent Progress in Research on Nutrition and Cancer. New York: Wiley-Liss, 1990, pp. 135–143.

    Google Scholar 

  2. Rimer BK, Engstrom PF. Participation in macronutrient trials. In Micozzi M, Moon T (eds): Nutrition and Cancer Prevention: Investigating the Role of Macronutrients. New York: Marcel Dekker, in press.

    Google Scholar 

  3. Turk DC. Nonadherence to chemoprevention regimens: A ton of prevention. In Aiken LH, Mechanic D (eds): Applications of Social Sciences to Clinical Medicine and Health Policy. New Brunswick: Rutgers University Press, 1990, pp. 139–149.

    Google Scholar 

  4. Glanz K. Nutrition education for risk factor reduction and patient education: A review. Prey Med 14:721–752, 1985.

    Article  CAS  Google Scholar 

  5. Arnold A, Johnstone B, Stoskopf B, Skingley P, Browman G, Levine M, Hryniuk W. Recruitment for an efficacy study in chemoprevention-The concerned smoker study. Prey Med 18:700–710, 1989.

    Article  CAS  Google Scholar 

  6. Leventhal H, Nerenz DR, Leventhal EA, Love RR, Bendena LM. The behavioral dynamics of clinical trials. Presented at “Workshop: “Antiestrogen Prevention of Breast Cancer.” Madison, WI, Oct 2–4, 1989.

    Google Scholar 

  7. Meiehenbaum D, Turk DC (eds). Facilitating Treatment Adherence-A Practitioner’s Guidebook. New York: Plenum Press, 1987.

    Google Scholar 

  8. Epstein LH, Cluss PA. A behavioral medicine perspective on adherence to long-tent medical regimens. J Consult ClinPsychol 50:950–971,1982.

    Article  CAS  Google Scholar 

  9. Hansen WB, Collins LM, Malone CK, Johnson CA, Fielding JE. Attrition in prevention research. J Behav Med 8(3):261–275,1985.

    Article  PubMed  CAS  Google Scholar 

  10. Greenwald P, Sondik EJ, Young JL. Emerging roles for cancer registries in cancer control. Yale J Biol Med 59:561–566,1986.

    PubMed  CAS  Google Scholar 

  11. Zelen M. Are primary cancer prevention trials feasible? J Natl Cancer Inst 80(18):1442–1444,1988.

    Article  PubMed  CAS  Google Scholar 

  12. Stevens M, Greenberg ER, Baron JA. Practical aspects of cancer prevention trials. In Moon T, Micozzi M (eds): Nutrition and Cancer Prevention. New York: Marcel Dekker, 1989, pp. 513–532.

    Google Scholar 

  13. Miller HH, Bauman LJ, DeCosse JJ. Psychosocial adjustment of familial polyposis patients and participation in a chemoprevention trial. Intl Psychiatry Med 16(3):211–230,1986.

    Article  Google Scholar 

  14. Gritz ER, DiMatteo MR, Hays RD. Methodological issues in adherence to cancer control regimens. Prey Med 18:711–720,1989.

    Article  CAS  Google Scholar 

  15. Powles TJ, Davey J, McKinna A. Chemoprevention of breast cancer. Acta Oncol 28:865–867, 1989.

    Article  PubMed  CAS  Google Scholar 

  16. Ho EE, Atwood JR, Meyskens FL Jr. Methodological development of dietary fiber intervention to lower colon cancer risk. In Engstrom PF, Mortenson LE, Anderson PN (eds): Advances in Cancer Control: The War on Cancer-15 Yews of Progress. New York: Alan R. Liss, 1987, pp. 263–281.

    Google Scholar 

  17. Boyd NF, Cousins M, Beaton M, Fishell E, Wright B, Fish E, Kriukov V, Lockwood G, Tritchler D, Hanna W, Page DL. Clinical trial of low-fat, high-carbohydrate diet in subjects with mammographie dysplasia: Report of early outcomes. J Natl Cancer Inst 80(15):1244–1248, 1988.

    Article  PubMed  CAS  Google Scholar 

  18. Romney SL, Dwyer A, Slagle S, Duttagupta C, Palan PR, Basu J, Calderin S, Kadish A. Chemoprevention of cervix cancer: Phase I-IC A feasibility study involving the topical vaginal administration of retinyl acetate gel. Gynecol Oncol 20:109–119, 1985.

    Article  PubMed  CAS  Google Scholar 

  19. Steering Committee of the Physicians’ Health Study Research Group. Final report on the aspirin component of the ongoing physicians’ health study. N Engl J Med 321(3):129–135, 1989.

    Article  Google Scholar 

  20. Dermatis H, Rowland J, MiranSky J, Kerner J, Osborne M, Holland J. Consent and compliance in chemoprevention trials. In Proceedings: The First International Breast Cancer Chemoprevention Workshop. New York: Marcel Dekker, 1988, pp. 633–635.

    Google Scholar 

  21. Browman GP, Arnold A, Booker L, Johnstone B, Skingley P, Levine MN. Etretinate blood levels in monitoring of compliance and contamination in a chemoprevention trial. J Natl Cancer Inst 81:795–798, 1989.

    Article  PubMed  CAS  Google Scholar 

  22. Berenson M, Groshen S, Miller H, DeCosse J. Subject-reported compliance in a chemoprevention trial for familial adenomatous polyposis. J Behav Mcd 12(3):233–247, 1989.

    Article  CAS  Google Scholar 

  23. Hong WK, Lippman SM, Uri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LI, Dimerly IW, Brown BW, Goepfert H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323(12):795–801,1990.

    Article  PubMed  CAS  Google Scholar 

  24. Henderson MM, Kushi LH, Thompson DJ, Gorbach SL, Clifford CK, Insull W, Moskowitz M, Thompson RS. Feasibility of a randomized trial of a low-fat diet for the prevention of breast cancer: Dietary compliance in the women’s health trial vanguard study. Prey Med 19:115–133, 1990.

    Article  CAS  Google Scholar 

  25. Morisky DE. Nonadherence to medical recommendations for hypertensive patients: Problems and potential solutions. Journal of Compliance in Health Care 1:5–20, 1986.

    Google Scholar 

  26. Becker MH, Maiman LA. Strategies for enhancing patient compliance. J Community Health 6:113–135,1980.

    Article  PubMed  CAS  Google Scholar 

  27. Higbee M, Dukes G, Bosso J. Patient recall of physician’s prescription instructions. Hospital Formulary 1.7:553–556,1982.

    Google Scholar 

  28. Hays R, DiMatteo MR. Key issues and suggestions for patient compliance assessment. Journal of Compliance in Health Care 2:37–53, 1987.

    Google Scholar 

  29. Loescher LJ, Graham VE, Aickin M, Meyskens FL Jr, Surwit EA. Development of a contingency recruitment plan fora phase III chemoprevention trial of cervical dysplasia. Prog Clin Biol Res 339:151–163, 1990.

    PubMed  CAS  Google Scholar 

  30. Chlebowski RT, Blackburn GL, Buzzard IM, Grosvenor M, Insult W, Nixon D, York RM, Khandekar J, Elashoff R, Wynder EL. Current status: Evaluation of dietary fat reduction as secondary breast cancer prevention. The Nutrition Adjuvant Study. In Aiken LH, Mechanic D (eds): Applications of Social Sciences to Clinical Medicine and Health Policy. New Brunswick, NJ: Rutgers University Press, 1986, 339:201–209.

    Google Scholar 

  31. Morris L, Halperin J. Effects of written drug information on patient knowledge and compliance: A literature review. Am J Public Health 69:47–52, 1979.

    Article  PubMed  CAS  Google Scholar 

  32. Ley P. Cognitive variables and noncompliance. Journal of Compliance in Health Care 1:171–188, 1986.

    Google Scholar 

  33. Turk DC, Salovey P, Litt MD. Adherence: A cognitive-behavioral perspective. In Gerber KE, Nehemkis AM (eds): Compliance: The Dilemma of the Chronically Ill. New York: Springer Publishing Company, 1986, pp.4472.

    Google Scholar 

  34. Black DM, Brand RJ, Greenlick M, Hughes G, Smith J. Compliance to treatment for hypertension in elderly patients: The SHEP pilot study. J Gerontol 42:552–557, 1987.

    Article  PubMed  CAS  Google Scholar 

  35. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 261:3273–3277,1989.

    Article  PubMed  CAS  Google Scholar 

  36. Rimer BK, Trock B, Lerman C, King B, Engstrom PS. Why do some women get regular mammograms? Am J Prey Med (in press).

    Google Scholar 

  37. Bell RL, Curb JD, Friedman LM, McIntyre KM, Payton-Ross C, The BRAT Research Group. Enhancement of visit adherence in the national bet -blocker heart attack trial. Controlled Clin Trials 6:89–101, 1985.

    Article  CAS  Google Scholar 

  38. Colletti G, Brownell K. The physical and emotional benefits of social support: Application to obesity, smoking, and alcoholism. In Hersen M, Eisler R, Miller PH (eds): Progress in Behavior Modification, vol. 13. New York: Academic Press, 1982,109–178.

    Google Scholar 

  39. Agras WS, Bradford RH. Recruitment: An introduction. Circulation 66 (Suppl IV):2–5, 1982.

    Google Scholar 

  40. Marty PJ, McDermott RJ, Christiansen K. Evaluation of two pedagogical techniques for enhancing knowledge, attitudes and frequency of practice related to breast self-examination. Health Education, November/December:25–28, 1983.

    Google Scholar 

  41. Carmody TP. Promoting adherence to heart-healthy diets: A review of the literature. Journal of Compliance in Health Care 2(2):105–124, 1987.

    Google Scholar 

  42. Davis AL, Faust R, Ordenlich M. Self-help smoking cessation and maintenance programs: A comparative study with 12-month follow-up by the American Lung Association. Am J Public Health 74:1212–1217,1984.

    Article  PubMed  CAS  Google Scholar 

  43. Glascow R, Schafer L, O’Neill HL. Self-help books and amount of therapist contact in smoking cessation programs. J Consult Clin Psychol 49:449–455, 1981.

    Google Scholar 

  44. Hoyt MF, Janis IL. Increasing adherence to a stressful decision via a motivational balance sheet procedure: A field experiment. J Pers Soc Psychol 31:833–839, 1975.

    Article  Google Scholar 

  45. Prue DM, Davis CJ, Martin JE, Moss RA. An investigation Of a minimal contact brand fading program for smoking treatment. Addict Behav 8:307–310, 1983.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fox Chase Cancer Center, Cheltenham, Pennsylvania, USA

    Barbara K. Rimer

  2. Cancer Control Research Program, Duke Comprehensive Cancer Center, Duke University Medical Center, Box 2949, Durham, NC, 27710, USA

    Barbara K. Rimer

Authors
  1. Barbara K. Rimer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

    Guy R. Newell  & Waun Ki Hong  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Rimer, B.K. (1992). Participant Enrollment, Participation, and Compliance in Chemoprevention Trials. In: Newell, G.R., Hong, W.K. (eds) The Biology and Prevention of Aerodigestive Tract Cancers. Advances in Experimental Medicine and Biology, vol 320. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3468-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3468-6_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6536-5

  • Online ISBN: 978-1-4615-3468-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation